Intas Pharmaceuticals Limited (the “Company”) is a leading, vertically integrated Indian pharmaceutical company with global operations, engaged in the development, manufacture and marketing of pharmaceutical formulation. The Company has filed a draft red herring prospectus (“DRHP”) with the Securities and Exchange Board of India (“SEBI”) and the stock exchanges for an initial public offering,(“IPO”).
The IPO will be made through apublic issue of equity shares of face value of Rs. 10 each (“Equity Shares”) including a share premium, which will be determinedon a later date,aggregating Rs. 2,250 million (“Fresh Issue”) and an offer for sale of 11,621,100 equity shares by Mozart Limited (the “Offer for Sale” and together with the Fresh Issue, the “Issue”).
The Issue is being made through the book building process, wherein not more than 50% of the Issue shall be allocated on a proportionate basis to Qualified Institutional Buyers (as defined in the SEBI(Issue of Capital and Disclosure Requirements), Regulations, 2009, as amended. The Company may, in consultation with the Book Running Lead Managers, allocate up to 30% of the QIB Portion to Anchor Investors at the Anchor Investor Allocation Price, on a discretionary basis, out of which at least one-third will be available for allocation to domestic mutual funds only.
The Promoters of the Company are Hasmukh Chudgar, Binish Hasmukh Chudgar, Mr. Nimish Hasmukhbhai Chudgar, Dr. UrmishHasmukh Chudgar, Ms. Kusum Chudgar, Ms. Bina Chudgar, Ms. Bindi Chudgar, Ms. Parul Chudgar, Mr. Shail Chudgar, Intas Enterprise Private Limited, Equatorial Private Limited, and Cytas Research Limited.
Kotak Mahindra Capital CompanyLimited and Morgan Stanley India Company Private Limited are the Book Running Lead Managers to the Issue and Link Intime India Private Limited is the Registrar to the Issue..
- Save upto Rs.2.67 lakh with Pradhan Mantri Awas Yojana ...Know more
- Now Save Rs.3150 on your Demat Account ...Click here
- Now get IIFL Personal Loan in just 8* hours...APPLY NOW!
- Get the most detailed result analysis on the web - Real Fast!
- Actionable & Award-Winning Research on 500 Listed Indian Companies.